Skip to main content

Michael DeFury

Analyst

Evercore

Equibles does not estimate personal net worth.

About Michael DeFury

Michael DeFury is recorded as Analyst at Evercore. Michael DeFury has spoken on 1 earnings call across 1 company, most recently for Altimmune, Inc. on November 12, 2026. The companies whose calls Michael DeFury spoke on are classified in the Healthcare sector.

Michael DeFury on recent calls

“Not sure if you disclosed in the past, but what placebo rate and treatment effect did you assume for Proforma's fibrosis endpoint, and how does that compare with impact?”
Analyst — Evercore, Q3 FY2026 Earnings conference call (announced in 8-K) ·

Affiliation history

  • Evercore

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity